Integra LifeSciences has announced several leadership appointments within its commercial organization. Robert T. Davis Jr. has been appointed executive vice president, Tissue Reconstruction and Distributed Technologies, leading wound reconstruction, soft tissue segments, and private label. Christopher Kilburn-Peterson has been promoted to corporate vice president and president for the Tissue Reconstruction division, reporting to Davis. Harvinder Singh has been appointed executive vice president and president of the Specialty Surgery division, succeeding Mike McBreen, who was recently named executive vice president and chief commercial officer. The changes are designed to strengthen customer focus, accelerate execution, and support long-term growth.
Integra LifeSciences HoldingsAppoints new commercial leadership to strengthen customer focus and accelerate execution, supporting long-term growth.